Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zuzana Mrkvová"'
Publikováno v:
Molecules, Vol 24, Iss 11, p 2152 (2019)
Tumor suppressor p53 is mutated in about 50% of cancers. Most malignant melanomas carry wild-type p53, but p53 activity is often inhibited due to overexpression of its negative regulators Mdm2 or MdmX. We performed high throughput screening of 2448 c
Externí odkaz:
https://doaj.org/article/ffa1f05628a74919a9a881dbc33d7d50
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2702, p 2702 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 5
International Journal of Molecular Sciences
Volume 22
Issue 5
Programmed cell death (PCD) pathways play a crucial role in the response of cancer cells to treatment. Their dysregulation is one of the cancer hallmarks and one of the reasons of drug resistance. Here, we studied the significance of the individual m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd2b3b31bac58f2fa26f3f80af5b918
https://pubmed.ncbi.nlm.nih.gov/33800107
https://pubmed.ncbi.nlm.nih.gov/33800107
Publikováno v:
Molecules
Volume 24
Issue 11
Molecules, Vol 24, Iss 11, p 2152 (2019)
Volume 24
Issue 11
Molecules, Vol 24, Iss 11, p 2152 (2019)
Tumor suppressor p53 is mutated in about 50% of cancers. Most malignant melanomas carry wild-type p53, but p53 activity is often inhibited due to overexpression of its negative regulators Mdm2 or MdmX. We performed high throughput screening of 2448 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9680240febb901df1bf0a4d005f260fb
https://pubmed.ncbi.nlm.nih.gov/31181622
https://pubmed.ncbi.nlm.nih.gov/31181622